- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 519/00 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
Patent holdings for IPC class C07D 519/00
Total number of patents in this class: 9876
10-year publication summary
|
524
|
616
|
633
|
662
|
760
|
816
|
970
|
1035
|
999
|
722
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4757 |
195 |
| Hoffmann-La Roche Inc. | 3832 |
185 |
| Gilead Sciences, Inc. | 2243 |
166 |
| Merck Sharp & Dohme LLC | 3734 |
164 |
| Incyte Corporation | 1070 |
163 |
| F. Hoffmann-La Roche AG | 7796 |
134 |
| Janssen Pharmaceutica N.V. | 3150 |
126 |
| Merck Patent GmbH | 5742 |
123 |
| Genentech, Inc. | 4123 |
116 |
| Boehringer Ingelheim International GmbH | 4488 |
110 |
| Takeda Pharmaceutical Company Limited | 2698 |
103 |
| Pfizer Inc. | 3414 |
101 |
| Amgen Inc. | 4445 |
92 |
| Novartis AG | 10174 |
79 |
| Revolution Medicines, Inc. | 337 |
66 |
| Idemitsu Kosan Co., Ltd. | 4269 |
64 |
| Array BioPharma Inc. | 438 |
62 |
| Samsung Display Co., Ltd. | 39012 |
59 |
| Medshine Discovery Inc. | 588 |
57 |
| ImmunoGen, Inc. | 375 |
55 |
| Other owners | 7656 |